2m 2m 2m 2m 2m 2m 2m
Propanc Biophrm (PPCB)
NASDAQ
$1.82-$0.02 (-1.03%)
Price as of Nov 12, 2026 9:25 AM EST- $19.0MMarket Cap
- -99.12%1-Year Change
- BiotechnologyIndustry
Propanc Biophrm (PPCB)
$1.82-$0.02 (-1.03%)
PPCB | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.84 | ||
Change | +$0.10 (+5.75%) | ||
Open | $1.85 | ||
High | $1.87 | ||
Low | $1.81 | ||
Previous Close | $1.74 | ||
Volume | 7,176 | ||
30-Day Average Volume | 40,142 | ||
1-Week Change | 2.79% | ||
1-Month Change | -62.12% | ||
1-Year Change | -99.12% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 10.3M | ||
Total Assets | $12.8M | ||
Market Cap | $19.0M | ||
Enterprise Value | $18.4M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$4.6M | ||
Free Cash Flow | -$1.6M | ||
EBIT | -$4.6M | ||
EBITDA | -$4.6M | ||
Net Working Capital | $5.2M | ||
EPS | $1.05 | ||
Enterprise Value/EBITDA | -4 | ||
Enterprise Value/Revenue | N/A | ||
P/B | N/A | ||
P/E | 2 | ||
PEG | 0 | ||
Price/Free Cash Flow | -12 | ||
Price/Operating Cash Flow | -12 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 10 | ||
Last Split Date | 10/26/2026 | ||
Earnings & Revenue